ArcBest Corp (ARCB) PT Raised to $89 at Wolfe Research
Tweet
Share
E-mailGet Alerts ARCB Hot Sheet
Price: $129.75 +0.79%
Rating Summary:
12 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
12 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Wolfe Research analyst Scott Group raised the price target on ArcBest Corp (NASDAQ: ARCB) to $89.00 (from $78.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- Kymera Therapeutics (KYMR) PT Raised to $152 at Stifel
- Antero Midstream Partners LP (AM) PT Lowered to $22 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
